Correction of Potentially Modified Risk Factors in Hemodialysis Treatment: Standards of Therapy and Individualized Programs of Dialysis

Authors

  • I.L. Kuchma National Medical Academy of Postgraduate Education named after P.L. Shupyk, Department of Nephrology and Renal Replacement Therapy, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2307-1257.0.3.13.2015.74930

Keywords:

chronic kidney disease, hemodialysis, arterial hypertension, treatment standards

Abstract

Limitations of possible correction for potentially modified factor the risk of death of patients, who are on renal replacement therapy, by techniques of hemodialysis were studied. The conclusions about the possibility of modern dialysis methods to effectively influence arterial hypertension in patients with chronic kidney disease stage 5D and the need of their further study in order to develop treatment standards with the use of mathematical models of individual dialysis programs were made.

Downloads

Download data is not yet available.

References

Національний реєстр хворих на хронічну хворобу нирок: 2012 рік / Уклад. Н.І. Козлюк, С.С. Ніколаєнко, М.В. Кулизький; Державна установа «Інститут нефрології НАМН України»; гол. ред. М.О. Колесник. — К., 2013. — 89 с.

Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics / Patrick H. Pun, Ruediger W. Lehrich, Emily F. Honeycutt, Charles A. Herzog and John P. Middleton // Kidney International. — 2011 Jan.— 79. — 218-227.

Наказ Національної академії медичних наук України, МОЗ України від 11 травня 2011 року № 280/44 «Про затвердження стандарту та уніфікованих клінічних протоколів надання медичної допомоги зі спеціальності «Нефрологія».

Levin A. Identification of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies // Nephrol. Dial. Transplant. — 2001. — 16, ­Suppl 7. — 57-60.

Pun P.H., Lehrich R.W., Honeycutt E.F., Herzog C.A., Middleton J.P. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics // Kidney Int. — 2011 Jan. — 79 (2). — 218-27.

Бикбов Б.Т. Выживаемость и факторы риска неблагоприятных исходов у больных на программном гемодиализе // Нефрология и диализ. — 2004. — Т. 6. — 280-296.

Короткий Д.В., Макеева Т.И., Заварицкая О.П., Земченков А.Ю. Артериальная гипертензия и гипертрофия миокарда на преддиализной стадии хронической болезни почек и при заместительной почечной терапии // Нефрология и диализ. — Т. 11. — 2009. — № 3. — С. 190-206.

Gunal A.I., Ilkay E., Kirciman E., Karaca I., Dogukan A., Celiker H. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodi alysis patients: a cross-sectional study // Perit. Dial. Int. — 2003. — Vol. 23 (6). — P. 563-567.

Downloads

Published

2022-01-19

How to Cite

Kuchma, I. (2022). Correction of Potentially Modified Risk Factors in Hemodialysis Treatment: Standards of Therapy and Individualized Programs of Dialysis. KIDNEYS, (3.13), 42–46. https://doi.org/10.22141/2307-1257.0.3.13.2015.74930

Issue

No. 3.13 (2015)

Section

Original Articles

License

Copyright (c) 2015 I.L. Kuchma

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.